81245 Flt3 gene
Also known as: FLT3 ITD testing, FLT3 gene analysis
Molecular analysis of the FLT3 gene to identify mutations including internal tandem duplications (ITD) associated with acute myeloid leukemia.
In Plain Language
acute leukemia gene test; blood cancer mutation screening
Clinical Context
Used to detect FLT3-ITD mutations in acute myeloid leukemia for prognostic stratification and FLT3 inhibitor eligibility assessment.
RVU Information
CPT 81245 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81245?
CPT 81245 (Flt3 gene) is a Pathology & Lab code. Molecular analysis of the FLT3 gene to identify mutations including internal tandem duplications (ITD) associated with acute myeloid leukemia.
Who uses CPT code 81245?
CPT 81245 is used by Hematology, Oncology, Pathology. Used to detect FLT3-ITD mutations in acute myeloid leukemia for prognostic stratification and FLT3 inhibitor eligibility assessment.
When is CPT 81245 used?
Used to detect FLT3-ITD mutations in acute myeloid leukemia for prognostic stratification and FLT3 inhibitor eligibility assessment.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.